The Intrauterine Devices Market is expected to grow positively due to factors including rising family planning awareness, high rates of unintended pregnancies that give rise to an increased tendency for planned or delayed pregnancies, and various healthcare initiatives by the government regarding contraception. The market for intrauterine devices is anticipated to expand at a consistent CAGR through 2027 due to rising family planning awareness and the increasing prevalence of unwanted pregnancies.
DelveInsight’s Intrauterine Devices Market Insights report provides the current and forecast market, forthcoming device innovation, individual leading companies’ market shares, challenges, Intrauterine Devices market drivers, barriers and trends, and key Intrauterine Devices companies in the market.
Intrauterine Devices
Doctors can prevent pregnancies by inserting small devices called intrauterine devices (IUDs) inside women’s uteruses. These implants provide protection against pregnancy for 5 to 10 years. These are one type of reversible long-acting birth contraception.
The Intrauterine Devices market is gaining momentum at present owing to the increasing awareness about family planning across the globe.
Intrauterine Devices Market Insights
Geographically, the global Intrauterine Devices market is studied in North America, Europe, Asia-Pacific, and the Rest of the World. In terms of the largest market share, the intrauterine devices market in North America is anticipated to develop faster than the rest of the world due to factors such as an increase in planned or delayed pregnancies and government measures to raise public awareness about family planning.
Higher female work, women’s increased education, and possible medical reasons are all contributing causes to the trend of planned and delayed pregnancies. Therefore, contraceptive techniques, such as Intrauterine Devices, can be favored to delay pregnancies because they are safe, effective, and long-lasting methods. Consequently, an increase in Intrauterine Devices demand would, in turn, create a favorable growth environment for the Intrauterine Devices market in the North American region.
To know more about why North America is leading the market growth in the Intrauterine Devices market, get a snapshot of the report Intrauterine Devices Market Trends
Recent Developments in the Intrauterine Devices Market Report
- In October 2021, Bayer announced to invest €400 million to expand access to modern contraception
- In August 2021, the launch of the Avibela hormonal intrauterine device in Kenya was announced by Medicines360, MSI Reproductive Choices, and MSK
- In December 2020, to assist the US launch of Intrauterine Ball (IUB), Ballerine Rhia Ventures invested in Israeli-based OCON Healthcare
- In May 2018, Medicines360 announced the launch of its hormonal IUD Avibela in Madagascar.
- Thus, owing to such developments in the market, rapid growth will be observed in the Intrauterine Devices market during the forecast period.
To read more about the latest highlights related to Intrauterine Devices, get a snapshot of the key highlights entailed in the Intrauterine Devices
Key Players in the Intrauterine Devices Market
Some of the key market players operating in the Intrauterine Devices market include CooperSurgical Inc, Bayer AG (BAYN), Odyssea Pharma SPRL (ODYY), Merck & Co Inc (MRK), Allergan Inc (AGN), EUROGINE S.L, OCON Medical Ltd, HLL Lifecare Limited, MonaLisa, Prosan International BV, SMB Corporation of India, Medicines360, AbbVie Inc (ABBV), Teva Pharmaceutical Industries Ltd (TEVA), Pregna International Limited, HRA Pharma, Melbea Innovations, Mylan N.V (VTRS), Meril Life Sciences Pvt. Ltd, and others.
COVID-19 Impact Analysis on the Intrauterine Devices Market
The global Intrauterine Devices market is expected to witness appreciable growth owing to the rising public knowledge of family planning. Nowadays, most parents choose family planning, which necessitates using contraceptives to postpone pregnancies or reduce the number of children. IUDs are superior to other contraceptive methods since they are 99% effective and offer long-term protection against pregnancy. As a result, rising contraceptive use will lead to rising IUD demand, which will fuel the expansion of the intrauterine devices market throughout the forecast period (2022-2027). The high incidence of unwanted pregnancies is yet another important aspect that may be to blame for the growth in the market for intrauterine devices. Every year, unwanted pregnancies cause abortions and maternal deaths worldwide in low- and middle-income nations. Women may benefit from using IUDs to address family planning issues and avoid unplanned pregnancies, unsafe abortions, and maternal deaths. Therefore, due to the above-mentioned considerations, the Intrauterine Devices market will grow throughout the forecast period.
Additionally, the unprecedented COVID-19 pandemic has had an effect on the intrauterine device market. People were required to stay at home due to lockdown regulations in numerous nations. As a result, they could not meet their sexual and reproductive demands, which led to a rise in unintended pregnancies. However, the intrauterine devices market has gained speed and is anticipated to expand during the projected period as more people receive vaccinations.
Scope of the Intrauterine Devices Market Report
- Coverage: Global
- Study Period: 2019–2027
- Market Segmentation By Product Type: Hormonal Intrauterine And Copper Intrauterine
- Market Segmentation By End User: Hospitals, Gynaecology Clinics, And Community Health Care Centres, and Others
- Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
- Key Intrauterine Devices Companies: CooperSurgical Inc, Bayer AG (BAYN), Odyssea Pharma SPRL (ODYY), Merck & Co Inc (MRK), Allergan Inc (AGN), EUROGINE S.L, OCON Medical Ltd, HLL Lifecare Limited, MonaLisa, Prosan International BV, SMB Corporation of India, Medicines360, AbbVie Inc (ABBV), Teva Pharmaceutical Industries Ltd (TEVA), Pregna International Limited, HRA Pharma, Melbea Innovations, Mylan N.V (VTRS), Meril Life Sciences Pvt. Ltd, among others
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
DelveInsight Analysis: The global Intrauterine Devices market size is expected to advance at a CAGR of 5.81% during the forecast period from 2022 to 2027
Which MedTech key players in the Intrauterine Devices market are set to emerge as the trendsetter explore @ Intrauterine Devices
Table of Contents
| 1 | Intrauterine Devices Market Report Introduction |
| 2 | Intrauterine Devices Market Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Intrauterine Devices Market Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Intrauterine Devices Market |
| 7 | Intrauterine Devices Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Company and Product Profiles |
| 10 | Project Approach |
| 11. | About DelveInsight |
Interested in knowing how the Intrauterine Devices market will grow by 2027? Click to get a snapshot of the Intrauterine Devices Market Analysis
Related Reports
Endoscopy Cameras Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Endoscopy Cameras Market companies including Olympus Corporation, Stryker, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, SCHÖLLY FIBEROPTIC GMBH, among others.
Endoscopes Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Endoscopes Market companies, including Boston Scientific Corporation, CONMED Corporation, OLYMPUS CORPORATION, PENTAX Medical, among others.
Disposable Endoscopes Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Disposable Endoscopes Market companies, including Olympus Corporation, Boston Scientific Corporation, Ambu Inc., ProSurg Inc., Hill-Rom Services, Inc. (Baxter), among others.
Endoscopic Ultrasound Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Endoscopic Ultrasound Market companies, including Abbott, Olympus, Intuitive Surgical Inc, Stryker, JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES, among others.
Gastrointestinal Endoscopic Stricture Management Devices Market
Gastrointestinal Endoscopic Stricture Management Devices Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and Gastrointestinal Endoscopic Stricture Management Devices Market companies including Stryker, JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES, Abbott, Olympus, Intuitive Surgical Inc, among others.
Other Trending Reports
Basal Cell Carcinoma Market | Birch Allergy Market | Bile Duct Neoplasm Market | Gingivitis Market | Lupus Nephritis Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Congestive Heart Failure Market | Gingivitis Market | Lupus Nephritis Market | Erythromelalgia Market | AL Amyloidosis Market | Primordial Dwarfism Market | Breast Pumps Market | Hyperuricemia Market | Helicobacter Pylori (H. pylori) Infection Market | AIDS Dementia- Market | Follicular Lymphoma Market | Chronic Pulmonary Hypertension Market | Adrenal Crisis Market | Retinoblastoma Market | Non-Cystic Fibrosis Bronchiectasis Market | Microsatellite Stable Colorectal Cancer Market | Chondrosarcoma Market | Sialidosis Market
Latest Healthcare Blogs
- Genital Warts Treatment Market
- Vaccines Market Outlook
- Top Cardiac Devices For Heart Disease Prevention
- Burn Treatment Landscape
- Chlamydia Treatment
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us
Gaurav Bora
info@delveinsight.com
+1(919)321-6187